Umezawa S, Ogawara S, Okamoto Y, Igawa M, Aonuma K, Inada M, Korenaga M, Hiroe M, Marumo F
Division of Internal Medicine, Yokosuka Kyosai Hospital.
J Cardiol. 1996 Nov;28(5):257-66.
The effects of nicorandil on coronary collateral circulation during exercise-induced ischemia were compared between the different donor arteries in 13 patients with effort angina, 7 with complete obstruction of the left anterior descending artery (LAD) with well-developed collateral vessels from the right coronary artery (RCA) (LAD group), and 6 with complete occlusion of the RCA (segment 2-3) with well-developed collateral vessels from the LAD (RCA group). Initial percentage thallium (%TI) uptake (thallium-201 single photon emission computed tomography) and washout rate were measured in the anterior, septal and posterior regions during ergometer exercise. The submaximal treadmill exercise test was also performed using a cardiopulmonary monitoring system to measure Vo2 at anaerobic threshold (AT). After the controls were obtained, nicorandil (15 mg/day) was administered for 4 weeks, during which ergometer exercise and treadmill exercise tests were carried out repeatedly. A significant improvement of initial %TI uptake on exercise was observed in the LAD group with nicorandil therapy, but no improvement was shown in the RCA group. The AT significantly increased after nicorandil treatment in the LAD group (13.9 +/- 0.38-->16.8 +/- 1.18 ml/min/kg), reflecting the improvement of cardiac function through the increased collateral flow. However, in the RCA group, it remained unchanged, suggesting no improvement of cardiac function. Nicorandil was effective to increase collateral flow from the RCA, but ineffective on that from the LAD. Nicorandil is an effective coronary dilator and is reported to affect both large and small coronary arteries. The effect on the collateral circulation is dependent on the donor artery supplying different areas. The vasodilator effect of nicorandil is mainly on the LAD, which is large enough to supply blood to a wider area of the heart, rather than the RCA.
在13例劳力性心绞痛患者中,比较了尼可地尔对运动诱发缺血期间冠状动脉侧支循环的影响。其中7例患者左前降支(LAD)完全闭塞,右冠状动脉(RCA)发出的侧支血管发育良好(LAD组);6例患者RCA(第2 - 3节段)完全闭塞,LAD发出的侧支血管发育良好(RCA组)。在测力计运动期间,测量前壁、间隔和后壁区域的初始铊摄取百分比(%TI)(铊 - 201单光子发射计算机断层扫描)和洗脱率。还使用心肺监测系统进行次极量跑步机运动试验,以测量无氧阈值(AT)时的Vo2。在获得对照值后,给予尼可地尔(15毫克/天)治疗4周,在此期间反复进行测力计运动和跑步机运动试验。在接受尼可地尔治疗的LAD组中,观察到运动时初始%TI摄取有显著改善,但RCA组未显示改善。LAD组在尼可地尔治疗后AT显著增加(13.9±0.38→16.8±1.18毫升/分钟/千克),反映出通过增加侧支血流使心脏功能得到改善。然而,在RCA组中,AT保持不变,表明心脏功能未改善。尼可地尔可有效增加来自RCA的侧支血流,但对来自LAD的侧支血流无效。尼可地尔是一种有效的冠状动脉扩张剂,据报道对大、小冠状动脉均有影响。对侧支循环的影响取决于供应不同区域的供血动脉。尼可地尔的血管扩张作用主要作用于LAD,LAD足够大,能够为心脏更广泛的区域供血,而不是RCA。